Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Overzicht 
Founder of 7 different companies, including: Moderna, Inc., Foghorn Therapeutics, Inc. and Syros Pharmaceuticals, Inc. Douglas G. Cole is an entrepreneur and presently occupies the position of Chairman of Sigilon Therapeutics, Inc. (which he founded in 2015), Chairman at Foghorn Therapeutics, Inc. (which he founded in 2015) and Managing Partner at Flagship Pioneering. Dr. Cole is also Member of The Phi Beta Kappa Society and on the board of 8 other companies.

In his past career he held the position of Program Executive at Vertex Pharmaceuticals, Inc., Principal at Selventa, Inc., Medical Director of CytoTherapuetics, Inc., Principal at Renovis, Inc., Principal at Hypnion, Inc., Member of Alpha Omega Alpha Honor Medical Society, Director at Ensemble Therapeutics Corp., Director at Permeon Biologics, Inc., Director at Syros Pharmaceuticals, Inc. and Director at Moderna, Inc.

Douglas G. Cole received an undergraduate degree from Dartmouth College, a doctorate from Perelman School of Medicine and a doctorate from the University of Pennsylvania Medical Center.


Posities en verantwoordelijkheden van Douglas G. Cole 
NaamTitel Van
Denali Therapeutics Inc.
(Biotechnologie & Medisch Onderzoek)
Independent Director 2015
Sana Biotechnology, Inc.
(Biotechnologie & Medisch Onderzoek)
Independent Director 2020
Foghorn Therapeutics Inc.
(Biotechnologie & Medisch Onderzoek)
Chairman -
Sigilon Therapeutics, Inc.
(Biotechnologie & Medisch Onderzoek)
Chairman -
TARIS BioMedical LLC Director -
Spinal Muscular Atrophy Foundation Director -
Torque Therapeutics, Inc. Director 2015
Birch Rock Camp Directors -
Repertoire Immune Medicines, Inc. Director -
Inzen Therapeutics, Inc. Director -
The Phi Beta Kappa Society Member -
Flagship Pioneering Managing Partner 2001


Belangnemingen van Douglas G. Cole 
NaamAandelen%Totale waarde
Denali Therapeutics Inc. (DNLI)
(Biotechnologie & Medisch Onderzoek)
5 3270,0044%283 396 USD


Douglas G. ColePersoonlijk netwerk 
Meest gelezen nieuws 
22/09WILLIAM ACKMAN : Ackman's Pershing Square fonds stijgt bij beursdebuut Universal
MR
24/09CATHIE WOOD : Chinese maatregelen tegen bitcoin opnieuw een klap voor Cathie Woods ARK ETF
MR
15/09BRAD SMITH : Microsoft kondigt inkoop van eigen aandelen aan tot $60 mrd, verhoogt dividend
MR
14/09STEPHEN SCHERR : Goldman Sachs benoemt Coleman als nieuwe CFO, ter vervanging van Scherr
MR
15/09ILHAM KADRI : Activist Bluebell Capital wil ontslag CEO Solvay
AM
Meer nieuws


© 2021 People and Ownership :   
Douglas G. Cole Verbindingen